glp-1 analog drugs Receptor Agonists as Treatments for Type 2 Diabetes The Impact of GLP-1 Receptor

According to their findings, 53.6% discontinued GLP-1 treatment by the end of year one, with higher rates of discontinuation (64.8%) seen among those using the drugs solely for weight loss, when compared with the 46.5% of those who quit after using the medications as a diabetes treatment

Tirzepatide: a promising drug for type 2 diabetes and beyond

K.JahnL

Learn more about our Weight Management programs or get the recap of our recent webinar with 9amHealth all about balancing cost with care

If youre a small employer who wants to cover these drugs, you can find another insurer that still offers that coverage

FDA steps in to regulate supply The reign of compounded GLP-1s appeared to end in February, when the U.S